CHARLES SCHWAB INVESTMENT MANAGEMENT INC - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 175 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$6,762,030
-56.7%
721,668
+13.3%
0.00%
-50.0%
Q2 2023$15,624,972
+10.0%
636,974
+4.4%
0.00%0.0%
Q1 2023$14,198,353
-23.7%
610,157
-17.0%
0.00%
-33.3%
Q4 2022$18,596,446
+48.1%
734,747
+12.8%
0.01%
+50.0%
Q3 2022$12,559,000
-35.9%
651,373
-15.4%
0.00%
-42.9%
Q2 2022$19,601,000
+2.2%
769,564
+3.3%
0.01%
+16.7%
Q1 2022$19,170,000
-37.0%
745,328
+2.6%
0.01%
-33.3%
Q4 2021$30,421,000
+0.1%
726,536
+4.0%
0.01%
-10.0%
Q3 2021$30,405,000
+9.3%
698,644
+18.7%
0.01%
+11.1%
Q2 2021$27,823,000
-2.6%
588,456
+5.6%
0.01%
-10.0%
Q1 2021$28,567,000
+96.7%
557,172
+2.7%
0.01%
+66.7%
Q4 2020$14,525,000
-21.1%
542,371
+1.1%
0.01%
-25.0%
Q3 2020$18,416,000
+346.9%
536,435
+433.4%
0.01%
+300.0%
Q2 2020$4,121,000
+691.0%
100,563
+561.7%
0.00%
Q1 2020$521,000
+167.2%
15,197
-1.7%
0.00%
Q4 2019$195,00015,4660.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$36,281,23432.04%
SB INVESTMENT ADVISERS (UK) LTD 18,319,938$426,304,9573.50%
Zebra Capital Management LLC 27,110$6313.15%
Avidity Partners Management LP 1,640,200$38,167,4541.27%
Sofinnova Investments, Inc. 657,559$15,301,3980.98%
DCF Advisers, LLC 62,000$1,442,7400.88%
SECTOR GAMMA AS 145,545$3,386,8320.82%
Temasek Holdings (Private) Ltd 5,814,972$135,314,3980.80%
BRAIDWELL LP 604,036$14,055,9180.46%
SummerHaven Investment Management, LLC 26,045$606,0670.35%
View complete list of VIR BIOTECHNOLOGY INC shareholders